# IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.

> **NCT00361114** · PHASE3 · TERMINATED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 112 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** sulphadoxine/pyrimethamine
- **DRUG:** Chlorproguanil/dapsone
- **DRUG:** Sulfadoxine/pyrimethamine

## Key facts

- **NCT ID:** NCT00361114
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2007-08
- **Final completion:** 2007-10
- **Target enrollment:** 112 (ACTUAL)
- **Why stopped:** SP arms were stopped due to high levels of treatment failure.CD not available.
- **Last updated:** 2017-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00361114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00361114, "IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00361114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*